JPMorgan raised the firm’s price target on Amicus (FOLD) to $174 from $16 and keeps an Overweight rating on the shares. The firm updated models in the Smid-cap biotechnology space.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on FOLD:
- Biotech Alert: Searches spiking for these stocks today
- Amicus price target raised to $21 from $20 at Cantor Fitzgerald
- Amicus price target raised to $15 from $13 at Guggenheim
- Amicus price target raised to $21 from $19 at UBS
- Amicus Therapeutics Reports Strong Q3 2024 Growth
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
